ASTELLAS PHARMA UNSP.ADR Capital Reinvestment Ratio
ASTELLAS PHARMA UNSP.ADR capital reinvestment ratio. ASTELLAS PHARMA UNSP.ADR (YPHA) has a Capital Reinvestment Ratio of 0.29x as of March 2025, meaning it reinvests 0% of its operating cash flow (€194.51 Billion) in capital expenditures (€57.33 Billion). Check ASTELLAS PHARMA UNSP.ADR (YPHA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ASTELLAS PHARMA UNSP.ADR (2022–2025)
Capital reinvestment ratio of ASTELLAS PHARMA UNSP.ADR from 2022 to 2025. This chart tracks ASTELLAS PHARMA UNSP.ADR's Capital Reinvestment Ratio across 4 annual periods. Also explore YPHA net assets growth trend to track the company's year-over-year net asset growth rate.
ASTELLAS PHARMA UNSP.ADR Capital Reinvestment Ratio by Year (2022–2025)
ASTELLAS PHARMA UNSP.ADR capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see ASTELLAS PHARMA UNSP.ADR (YPHA) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | €194.51 Billion | €57.33 Billion | ▼ -38.4% |
| 2024 | 0.48x | €172.47 Billion | €82.50 Billion | ▲ +77.1% |
| 2023 | 0.27x | €327.77 Billion | €88.54 Billion | ▼ -9.0% |
| 2022 | 0.30x | €257.44 Billion | €76.45 Billion | — |